Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus

被引:826
作者
Nowotny, Kerstin [1 ]
Jung, Tobias [1 ]
Hoehn, Annika [1 ]
Weber, Daniela [1 ]
Grune, Tilman [1 ]
机构
[1] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Toxicol, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany
关键词
advanced glycation end products; oxidative stress; type 2 diabetes mellitus; insulin resistance; cell dysfunction; diabetic complications;
D O I
10.3390/biom5010194
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Type 2 diabetes mellitus (T2DM) is a very complex and multifactorial metabolic disease characterized by insulin resistance and cell failure leading to elevated blood glucose levels. Hyperglycemia is suggested to be the main cause of diabetic complications, which not only decrease life quality and expectancy, but are also becoming a problem regarding the financial burden for health care systems. Therefore, and to counteract the continually increasing prevalence of diabetes, understanding the pathogenesis, the main risk factors, and the underlying molecular mechanisms may establish a basis for prevention and therapy. In this regard, research was performed revealing further evidence that oxidative stress has an important role in hyperglycemia-induced tissue injury as well as in early events relevant for the development of T2DM. The formation of advanced glycation end products (AGEs), a group of modified proteins and/or lipids with damaging potential, is one contributing factor. On the one hand it has been reported that AGEs increase reactive oxygen species formation and impair antioxidant systems, on the other hand the formation of some AGEs is induced per se under oxidative conditions. Thus, AGEs contribute at least partly to chronic stress conditions in diabetes. As AGEs are not only formed endogenously, but also derive from exogenous sources, i.e., food, they have been assumed as risk factors for T2DM. However, the role of AGEs in the pathogenesis of T2DM and diabetic complicationsif they are causal or simply an effectis only partly understood. This review will highlight the involvement of AGEs in the development and progression of T2DM and their role in diabetic complications.
引用
收藏
页码:194 / 222
页数:29
相关论文
共 167 条
[21]   AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-δ: implications for vascular disease [J].
Cai, Weijing ;
Torreggiani, Massimo ;
Zhu, Li ;
Chen, Xue ;
He, John Cijiang ;
Striker, Gary E. ;
Vlassara, Helen .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2010, 298 (03) :C624-C634
[22]   In Skeletal Muscle Advanced Glycation End Products (AGEs) Inhibit Insulin Action and Induce the Formation of Multimolecular Complexes Including the Receptor for AGEs [J].
Cassese, Angela ;
Esposito, Iolanda ;
Fiory, Francesca ;
Barbagallo, Alessia P. M. ;
Paturzo, Flora ;
Mirra, Paola ;
Ulianich, Luca ;
Giacco, Ferdinando ;
Iadicicco, Claudia ;
Lombardi, Angela ;
Oriente, Francesco ;
Van Obberghen, Emmanuel ;
Beguinot, Francesco ;
Formisano, Pietro ;
Miele, Claudia .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (52) :36088-36099
[23]   Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products [J].
Chakravarthy, U ;
Hayes, RG ;
Stitt, AW ;
McAuley, E ;
Archer, DB .
DIABETES, 1998, 47 (06) :945-952
[24]   INHIBITION OF LAMININ SELF-ASSEMBLY AND INTERACTION WITH TYPE-IV COLLAGEN BY ANTIBODIES TO THE TERMINAL DOMAIN OF THE LONG ARM [J].
CHARONIS, AS ;
TSILIBARY, EC ;
SAKU, T ;
FURTHMAYR, H .
JOURNAL OF CELL BIOLOGY, 1986, 103 (05) :1689-1697
[25]   The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: A novel pathway for inflammatory cell recruitment [J].
Chavakis, T ;
Bierhaus, A ;
Al-Fakhri, N ;
Schneider, D ;
Witte, S ;
Linn, T ;
Nagashima, M ;
Morser, J ;
Arnold, B ;
Preissner, KT ;
Nawroth, PP .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (10) :1507-1515
[26]   Advanced glycation endproducts alter functions and promote apoptosis in endothelial progenitor cells through receptor for advanced glycation endproducts mediate overpression of cell oxidant stress [J].
Chen, Jianfei ;
Song, Minbao ;
Yu, Shiyong ;
Gao, Pan ;
Yu, Yang ;
Wang, Hong ;
Huang, Lan .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2010, 335 (1-2) :137-146
[27]   Methylglyoxal inhibits the binding step of collagen phagocytosis [J].
Chong, Sandra A. C. ;
Lee, Wilson ;
Arora, Pam D. ;
Laschinger, Carol ;
Young, Edmond W. K. ;
Simmons, Craig A. ;
Manolson, Morris ;
Sodek, Jaro ;
McCulloch, Christopher A. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (11) :8510-8520
[28]   Advanced Glycation End-Products Induce Tubular CTGF via TGF-β-Independent Smad3 Signaling [J].
Chung, Arthur C. K. ;
Zhang, Haiyan ;
Kong, Yao-Zhong ;
Tan, Jia-Ju ;
Huang, Xiao R. ;
Kopp, Jeffrey B. ;
Lan, Hui Y. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (02) :249-260
[29]   INHIBITION OF FIBRONECTIN BINDING TO MATRIX COMPONENTS BY NONENZYMATIC GLYCOSYLATION [J].
COHEN, MP ;
KU, LN .
DIABETES, 1984, 33 (10) :970-974
[30]   Advanced Glycation End Products Are Direct Modulators of β-Cell Function [J].
Coughlan, Melinda T. ;
Yap, Felicia Y. T. ;
Tong, David C. K. ;
Andrikopoulos, Sofianos ;
Gasser, Anna ;
Thallas-Bonke, Vicki ;
Webster, Diane E. ;
Miyazaki, Jun-ichi ;
Kay, Thomas W. ;
Slattery, Robyn M. ;
Kaye, David M. ;
Drew, Brian G. ;
Kingwell, Bronwyn A. ;
Fourlanos, Spiros ;
Groop, Per-Henrik ;
Harrison, Leonard C. ;
Knip, Mikael ;
Forbes, Josephine M. .
DIABETES, 2011, 60 (10) :2523-2532